120 likes | 134 Views
Get more information about the market: https://www.imarcgroup.com/tumor-ablation-market<br><br>The global tumor ablation market size reached US$ 538.7 Million in 2018. On account of these factors, the market value is projected to reach US$ 1,080 Million by 2024, expanding at a CAGR of around 12% during the forecast period (2019-2024).<br><br>Want more information about this market? Request a free report sample: https://www.imarcgroup.com/tumor-ablation-market/requestsample<br><br>For India market research reports, visit: http://www.marketresearchindia.co.in<br><br>Contact US: <br><br>IMARC Group<br>30 N Gould St, Ste R<br>Sheridan, WY 82801, USA<br>Website: https://www.imarcgroup.com/<br>Email: sales@imarcgroup.com<br>USA: 1-631-791-1145<br>Follow us on twitter: @imarcglobal<br>Linkedin: https://www.linkedin.com/company/imarc-group
E N D
Global Tumor Ablation Market Research Report and Forecast 2024 Report Edition: 2019 Copyright © IMARC Service Pvt Ltd. All Rights Reserved © 2019 IMARC All Rights Reserved
Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Tumor Ablation Market Overview: According to the latest report by IMARC Group, titled “Tumor Ablation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the global tumor ablation market size reached US$ 538.7 Million in 2018. Tumor ablation is a minimally invasive (MI) surgery, which is utilized in the treatment of bone, liver, kidney and lung tumor. It is also considered as a potential first-line treatment for numerous patients with small hepatocellular carcinomas or benign tumors. During the procedure, a specialized needle-like probe is inserted at the precise location of the tumor and then energy is employed for heating or cooling the tissue to cytotoxic levels. Generally, laser, radio- frequency (RF), and microwave (MW) systems are used for heating the tissue to at least 60 degrees Celsius for maximum efficacy. Global Tumor Ablation Market Trends: According to the World Health Organization (WHO), cancer represents one of the leading causes of death across the globe. This can be attributed to sedentary lifestyles, high body mass index, low consumption of fruits and vegetables, and regular consumption of tobacco as well as alcohol. The rising prevalence of cancer, in confluence with benefits offered by MI procedures, such as speedy recovery, less trauma and reduced complications, is strengthening the global tumor ablation market growth.
Report Description and Highlights Report Description 186.5 181.2 120.2125.5130.8136.1141.4146.7152.0157.3 175.9 170.6 160 180 165.3 160.0 160 140 140 120 In Million US$ In Million US$ 120 100 100 80 80 60 60 40 40 20 20 0 0 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Apart from this, governments of various countries are investing in cancer awareness programs to minimize their healthcare expenditure, which in turn is also impelling the market growth. On account of these factors, the market value is projected to reach US$ 1,080 Million by 2024, expanding at a CAGR of around 12% during the forecast period (2019-2024). Request for a free sample report: https://www.imarcgroup.com/tumor-ablation- market/requestsample
Report Description and Highlights Report Description Furthermore, the advent of technological advancements, such as thermal and laser ablation, irreversible electroporation and High-Intensity Focused Ultrasound (HIFU), is anticipated to boost the market in the coming years. Global Tumor Ablation Market Segmentation Market Breakup by Technology • • • • Radiofrequency (RF) Ablation Microwave Ablation Cryoablation Others Based on the technology, the market has been segmented into radiofrequency (RF) ablation, microwave ablation, cryoablation and others. Market Breakup by Mode of Treatment • Percutaneous Ablation
Report Description and Highlights Report Description • • Laparoscopic Ablation Surgical Ablation On the basis of the mode of treatment, the market has been segregated into percutaneous, laparoscopic and surgical ablation. Market Segmentation by Application • • • • • Liver Cancer Lung Cancer Kidney Cancer Bone Metastasis Others The market has been analyzed on the basis of the application into liver cancer, lung cancer, kidney cancer, bone metastasis and others. For more information, click here: https://www.imarcgroup.com/tumor-ablation-market
Report Description and Highlights Report Description Market Segmentation by End User • • • Hospitals Cancer Specialty Clinics Others Based on the end user, the market has been classified into hospitals, cancer specialty clinics and others. Market Segmentation by Region • • • • • North America Europe Asia Pacific Middle East and Africa Latin America Region-wise, the market has been divided into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America.
Report Description and Highlights Report Description Competitive Landscape: The competitive landscape of the market has also been examined with some of the key players. • • • • • • • • • • • • • • • Medtronic AngioDynamics Inc HealthTronics Inc NeuWave Medical INTIO Inc Galil Medical Ltd Boston Scientific Sonacare Medical EDAP TMS S.A. ERBE Elektromedizin GmbH IceCure Medical Ltd MISONIX Inc Endocare Inc CooperSurgical Inc B V M Meditech Pvt
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com